Chaidiscovery
Chai is a research lab working on AI to unlock biology. Our models design new molecules for new medicines. We are changing how biologists develop drugs, just as language models are changing how engineers write code.
CORE INFO
Chai Discovery is a biotechnology company that uses artificial intelligence to design new molecules, aiming to transform drug discovery by creating medicines more efficiently. Their AI platforms are utilized by major pharmaceutical companies to enhance drug development processes.
- Chai Discovery raised $130 million in a Series B funding round led by General Catalyst and Oak HC/FT, reaching a valuation of $1.3 billion.techcrunch.com
- The company collaborates with pharmaceutical giants like Pfizer and Eli Lilly to deploy their AI models in drug discovery.linkedin.com
- TechCrunch reported on Chai Discovery's rapid funding success and its position in the AI-driven drug development sector.techcrunch.com
WHY WE WOULD WORK AT CHAI DISCOVERY
Revolutionary Mission
Join a team dedicated to transforming drug discovery through AI, systematically engineering new medicines instead of relying on trial and error.
Collaborative Culture
Work alongside a talented team of innovators, including experts from OpenAI and Stripe, fostering a collaborative environment that values diverse perspectives.
Competitive Compensation
Benefit from a strong funding base of $130M in Series B, ensuring competitive salaries and resources for employee growth and development.
Cutting-Edge Technology
Utilize advanced AI models like Chai-3, which have doubled the success rate in antibody design, pushing the boundaries of biotechnology.
Notable Partnerships
Collaborate with industry giants like Pfizer and Eli Lilly, gaining exposure to high-impact projects that shape the future of pharmaceuticals.
Innovative Impact
Contribute to a mission that aims to accelerate therapeutic development, making a tangible difference in the lives of patients worldwide.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
NOTABLE CUSTOMERS
KEY METRICS
✦ KEY METRICGROWTH TACTICS
COMPETITIVE ADVANTAGE
PRODUCT AND TECH
AI-Driven Drug Discovery
Chai Discovery utilizes artificial intelligence to revolutionize the drug discovery process by designing new molecules and predicting biochemical interactions, significantly accelerating therapeutic development.
Molecular Design Platform
The company's AI-driven platform enables the generation of drug-like antibodies and molecular candidates with desired properties, reducing reliance on traditional trial-and-error methods.
Collaboration with Pharma Giants
Chai Discovery partners with major pharmaceutical companies like Pfizer and Eli Lilly to deploy its AI models, enhancing drug discovery efforts and fostering innovation in the biotech industry.
Chai-3 AI Model
The Chai-3 model represents a significant advancement in AI-driven antibody design, doubling the success rate of its predecessors and showcasing the company's commitment to improving drug development outcomes.
Engineering Biology Approach
Chai Discovery aims to transform biology into an engineering discipline, systematically designing new medicines with precision and speed, rather than relying on serendipitous discoveries.